Performance of European Member States in biotechnology
AbstractDespite an increasing policy interest in biotechnology in Europe, there is a lack of internationally comparable data on national performance in biotechnology. This paper presents a performance analysis of 14 Member States using science technology and economic indicators. A strong relationship between scientific and commercial performance was found. Four performance clusters were identified: the best-performing countries Denmark, Sweden and Finland; the second-best performers The Netherlands, the United Kingdom, Belgium and Germany; cluster three with Austria, France and Ireland, performing below the European median performance value, and the Mediterranean countries Italy, Spain, Portugal and Greece performing weakly as measured by all indicators. Copyright , Beech Tree Publishing.
Download InfoIf you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
Bibliographic InfoArticle provided by Oxford University Press in its journal Science and Public Policy.
Volume (Year): 31 (2004)
Issue (Month): 5 (October)
Contact details of provider:
You can help add them by filling out this form.
CitEc Project, subscribe to its RSS feed for this item.
- Chung, Chao-chen, 2013. "Government, policy-making and the development of innovation system: The cases of Taiwanese pharmaceutical biotechnology policies (2000–2008)," Research Policy, Elsevier, vol. 42(5), pages 1053-1071.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Oxford University Press) or (Christopher F. Baum).
If references are entirely missing, you can add them using this form.